臨床試驗

Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer

NCT：NCT06667752 · ACTIVE_NOT_RECRUITING

NCT IDNCT06667752

狀態ACTIVE_NOT_RECRUITING

開始日期2024-10-17

完成時間2026-12-31

SponsorNanordica Medical OU (INDUSTRY)

First posted2024-10-31

Last updated2026-09-18

簡要摘要

This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 136 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。